MoonLake Immunotherapeuti Financials
| MLTX Stock | USD 54.43 0.19 0.35% |
MoonLake |
Please note, the imprecision that can be found in MoonLake Immunotherapeuti's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of MoonLake Immunotherapeutics. Check MoonLake Immunotherapeuti's Beneish M Score to see the likelihood of MoonLake Immunotherapeuti's management manipulating its earnings.
MoonLake Immunotherapeuti Stock Summary
MoonLake Immunotherapeuti competes with Terns Pharmaceuticals, Day One, Acumen Pharmaceuticals, Amylyx Pharmaceuticals, and Aerovate Therapeutics. MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. MoonLake Immunotherapeutics was founded in 2021 and is headquartered in Zug, Switzerland. Moonlake Immunotherapeuti is traded on NASDAQ Exchange in the United States.Specialization | Healthcare, Biotechnology |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| CUSIP | 61559X104 G4444C102 |
| Location | Massachusetts; U.S.A |
| Business Address | Dorfstrasse 29, Zug, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.moonlaketx.com |
| Phone | 41 415108022 |
| Currency | USD - US Dollar |
MoonLake Immunotherapeuti Key Financial Ratios
| Return On Equity | -0.17 | ||||
| Return On Asset | -0.13 | ||||
| Target Price | 73.92 | ||||
| Number Of Employees | 50 | ||||
| Beta | 1.28 |
MoonLake Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining MoonLake Immunotherapeuti's current stock value. Our valuation model uses many indicators to compare MoonLake Immunotherapeuti value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across MoonLake Immunotherapeuti competition to find correlations between indicators driving MoonLake Immunotherapeuti's intrinsic value. More Info.MoonLake Immunotherapeutics is regarded second in return on equity category among its peers. It is regarded third in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the MoonLake Immunotherapeuti's earnings, one of the primary drivers of an investment's value.MoonLake Immunotherapeuti Systematic Risk
MoonLake Immunotherapeuti's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. MoonLake Immunotherapeuti volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on MoonLake Immunotherapeuti correlated with the market. If Beta is less than 0 MoonLake Immunotherapeuti generally moves in the opposite direction as compared to the market. If MoonLake Immunotherapeuti Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one MoonLake Immunotherapeuti is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of MoonLake Immunotherapeuti is generally in the same direction as the market. If Beta > 1 MoonLake Immunotherapeuti moves generally in the same direction as, but more than the movement of the benchmark.
Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as MoonLake Immunotherapeuti is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of MoonLake has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if MoonLake Immunotherapeuti's financials are consistent with your investment objective using the following steps:- Review MoonLake Immunotherapeuti's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand MoonLake Immunotherapeuti's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare MoonLake Immunotherapeuti's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if MoonLake Immunotherapeuti's stock is overvalued or undervalued.
MoonLake Immunotherapeuti December 2, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of MoonLake Immunotherapeuti help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of MoonLake Immunotherapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of MoonLake Immunotherapeutics based on widely used predictive technical indicators. In general, we focus on analyzing MoonLake Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build MoonLake Immunotherapeuti's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.15 | |||
| Information Ratio | 0.0519 | |||
| Maximum Drawdown | 16.94 | |||
| Value At Risk | (4.33) | |||
| Potential Upside | 4.74 |
Additional Tools for MoonLake Stock Analysis
When running MoonLake Immunotherapeuti's price analysis, check to measure MoonLake Immunotherapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MoonLake Immunotherapeuti is operating at the current time. Most of MoonLake Immunotherapeuti's value examination focuses on studying past and present price action to predict the probability of MoonLake Immunotherapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MoonLake Immunotherapeuti's price. Additionally, you may evaluate how the addition of MoonLake Immunotherapeuti to your portfolios can decrease your overall portfolio volatility.